Epidemiology of Plasmodium malariae and Plasmodium ovale spp. in Kinshasa Province, Democratic Republic of Congo.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
19 10 2023
Historique:
received: 06 04 2023
accepted: 03 10 2023
medline: 23 10 2023
pubmed: 20 10 2023
entrez: 19 10 2023
Statut: epublish

Résumé

Reports suggest non-falciparum species are an underappreciated cause of malaria in sub-Saharan Africa but their epidemiology is ill-defined, particularly in highly malaria-endemic regions. We estimated incidence and prevalence of PCR-confirmed non-falciparum and Plasmodium falciparum malaria infections within a longitudinal study conducted in Kinshasa, Democratic Republic of Congo (DRC) between 2015-2017. Children and adults were sampled at biannual household surveys and routine clinic visits. Among 9,089 samples from 1,565 participants, incidences of P. malariae, P. ovale spp., and P. falciparum infections by 1-year were 7.8% (95% CI: 6.4%-9.1%), 4.8% (95% CI: 3.7%-5.9%) and 57.5% (95% CI: 54.4%-60.5%), respectively. Non-falciparum prevalences were higher in school-age children, rural and peri-urban sites, and P. falciparum co-infections. P. falciparum remains the primary driver of malaria in the DRC, though non-falciparum species also pose an infection risk. As P. falciparum interventions gain traction in high-burden settings, continued surveillance and improved understanding of non-falciparum infections are warranted.

Identifiants

pubmed: 37857597
doi: 10.1038/s41467-023-42190-w
pii: 10.1038/s41467-023-42190-w
pmc: PMC10587068
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6618

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI129812
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI132547
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI070114
Pays : United States
Organisme : NIAID NIH HHS
ID : K24 AI134990
Pays : United States
Organisme : NIAID NIH HHS
ID : L30 AI164494
Pays : United States

Commentaires et corrections

Type : UpdateOf

Informations de copyright

© 2023. Springer Nature Limited.

Références

Malar J. 2016 Jan 13;15:27
pubmed: 26762532
Sci Rep. 2021 Mar 22;11(1):6495
pubmed: 33753817
PLoS Med. 2013 Dec;10(12):e1001575; discussion e1001575
pubmed: 24358031
Lancet. 1994 Apr 30;343(8905):1095
pubmed: 7909108
Malar J. 2017 Mar 11;16(1):112
pubmed: 28284211
Trans R Soc Trop Med Hyg. 2000 Jul-Aug;94(4):399-403
pubmed: 11127243
J Infect Dis. 2021 Mar 29;223(6):1005-1014
pubmed: 32766832
Diagn Microbiol Infect Dis. 2016 May;85(1):16-8
pubmed: 26915637
PLoS Negl Trop Dis. 2019 May 28;13(5):e0007414
pubmed: 31136585
Malar J. 2011 Jun 09;10:161
pubmed: 21658268
J Infect Dis. 2018 Mar 13;217(7):1099-1109
pubmed: 29325068
Health Place. 2021 Jul;70:102581
pubmed: 34020231
Malar J. 2021 Aug 5;20(1):337
pubmed: 34353333
PLoS One. 2020 Jun 19;15(6):e0235014
pubmed: 32559238
Malar J. 2017 Nov 09;16(1):456
pubmed: 29121931
Trends Parasitol. 2007 Jun;23(6):278-83
pubmed: 17459775
J Clin Microbiol. 2004 Dec;42(12):5636-43
pubmed: 15583293
Antimicrob Agents Chemother. 2003 Aug;47(8):2418-23
pubmed: 12878499
Malar J. 2021 Oct 2;20(1):389
pubmed: 34600558
Br Med J. 1963 Jul 6;2(5348):27-31
pubmed: 13947894
Nat Commun. 2021 Jul 7;12(1):4169
pubmed: 34234124
PLoS Negl Trop Dis. 2015 Dec 31;9(12):e0004195
pubmed: 26720002
Malar Res Treat. 2016;2016:5405802
pubmed: 26942036
Am J Trop Med Hyg. 1995 Jun;52(6):565-8
pubmed: 7611566
Malar J. 2021 Oct 29;20(1):425
pubmed: 34715876
PLoS One. 2011 Jan 31;6(1):e16420
pubmed: 21305011
PLoS One. 2020 Nov 23;15(11):e0242713
pubmed: 33227017
Malar J. 2017 Nov 7;16(1):448
pubmed: 29115954
Acta Trop. 2010 Dec;116(3):167-72
pubmed: 20727338
J Infect Dis. 2022 Jan 18;225(2):257-268
pubmed: 34244739
PLoS Negl Trop Dis. 2019 Jan 31;13(1):e0007140
pubmed: 30703083
Clin Microbiol Rev. 2007 Oct;20(4):579-92
pubmed: 17934075
Emerg Infect Dis. 2017 Apr;23(4):601-610
pubmed: 28322694
Nat Commun. 2023 Oct 19;14(1):6618
pubmed: 37857597
Lancet Microbe. 2021 Apr;2(4):e141-e150
pubmed: 35544189
Malar J. 2013 Aug 13;12:284
pubmed: 23941281
Malar J. 2018 Sep 20;17(1):334
pubmed: 30236117
Malar J. 2016 Jul 08;15:350
pubmed: 27392905
J Clin Microbiol. 2009 Apr;47(4):975-80
pubmed: 19244467
J Infect Dis. 2021 Jun 4;223(11):1948-1952
pubmed: 33057671
Parasit Vectors. 2021 Jun 3;14(1):297
pubmed: 34082791
PLoS One. 2008 Jul 23;3(7):e2775
pubmed: 18648666

Auteurs

Rachel Sendor (R)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. rachel.sendor@unc.edu.

Kristin Banek (K)

Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Melchior M Kashamuka (MM)

Ecole de Santé Publique, Faculté de Médecine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Nono Mvuama (N)

Ecole de Santé Publique, Faculté de Médecine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Joseph A Bala (JA)

Ecole de Santé Publique, Faculté de Médecine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Marthe Nkalani (M)

Ecole de Santé Publique, Faculté de Médecine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Georges Kihuma (G)

Ecole de Santé Publique, Faculté de Médecine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Joseph Atibu (J)

Ecole de Santé Publique, Faculté de Médecine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Kyaw L Thwai (KL)

Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

W Matthew Svec (WM)

University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Varun Goel (V)

Department of Geography, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Tommy Nseka (T)

Ecole de Santé Publique, Faculté de Médecine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Jessica T Lin (JT)

Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Division of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Jeffrey A Bailey (JA)

Department of Pathology and Laboratory Medicine and Center for Computational Molecular Biology, Brown University, Providence, RI, USA.

Michael Emch (M)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Department of Geography, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Margaret Carrel (M)

Department of Geographical and Sustainability Sciences, University of Iowa, Iowa City, IA, USA.

Jonathan J Juliano (JJ)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Division of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Antoinette Tshefu (A)

Ecole de Santé Publique, Faculté de Médecine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Jonathan B Parr (JB)

Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. jonathan_parr@med.unc.edu.
Division of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. jonathan_parr@med.unc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH